BNCM | DELEX Merger

Menu
Get In Touch

BNCM Announcement: DELEX Pharma Expands into the Online Pharmacy Market in the Philippines, Leveraging the Booming E-Pharmacy Sector in Asia

DELEX Pharma is excited to announce its strategic expansion into the rapidly growing online pharmacy market in the Philippines, as part of a broader initiative to tap into the booming e-pharmacy sector across Asia. This expansion reflects the company’s ongoing commitment to improving patient access to healthcare products and services through innovative, digital-first solutions. With the Asian online pharmacy market expected to reach a value of $[insert market value] billion by [insert forecast year], DELEX Pharma is well-positioned to capture a share of this growing opportunity and drive substantial growth for patients and investors.

BNCM Announcement: DELEX Accelerates Market Leadership with Major Expansion into Medical Device Sector

DELEX Pharma, a dominant force in the Philippine healthcare market, is set to revolutionize the medical device industry through a strategic expansion that positions the company for explosive growth. Building on its solid foundation in the pharmaceutical sector, DELEX Pharma is now advancing into the rapidly growing medical device market, capitalizing on new partnerships and cutting-edge technology to deliver world-class healthcare solutions to a broader range of patients and healthcare providers.

DELEX Healthcare Group Inc. Profitable, Fast-Growing Pharma Company Revolutionizing Critical Care Meeting the Gaps in Critical Care with Innovative Pharmaceutical Solutions

Delex Healthcare Group Inc. (DELEX), a rapidly expanding pharmaceutical and healthcare company, continues to make significant strides in addressing critical care challenges. Founded in 2017 and incorporated in Delaware, USA, DELEX specializes in the development, distribution, and marketing of pharmaceutical products through its subsidiaries, including DELEX Pharma International Inc. (DELEX Pharma), DLX Holdings Corp., and JMN Brother’s Pharma Limited Inc.

BNCM / DELEX Unveils 11 New Pharmaceutical Products and Strengthens Position in Global Healthcare Market

DELEX Pharma, a global leader in pharmaceutical innovation, is intensifying its expansion efforts with the launch of 11 new pharmaceutical products and key partnerships with multinational medical device firms. This bold move underscores the company’s commitment to meeting the evolving needs of healthcare professionals and patients worldwide, while significantly enhancing its product portfolio.

BNCM: DELEX ANNOUNCE EXPANSION PLANS FOR ITS PHARMACY

The Philippines, with its population exceeding 114 million across 7,641 islands, presents a strong opportunity for growth in the pharmacy retail industry. The countrys expanding population, rising economy, and increasing incomes are driving higher demand globally for healthcare products and services.

BNCM Announces the Expansion of DELEX PHARMA’s Medical Device Business

9th September 2024 BNCM announces today the expansion of DELEX PHARMAs medical device business through its strategic partnerships with leading international medical device companies in the US and Germany. These collaborations are expected to contribute around 30% of the companys total revenue, reinforcing DELEXs rapid growth in the healthcare sector.

BNCM Announces 11 New Products from DELEX PHARMA to Propel Growth

3rd September 2024, Quezon City, Philippines Delex Pharma International Inc. has launched an impressive array of 11 new pharmaceutical products in the first half of 2024, setting the stage for significant growth across multiple therapeutic areas. This launch reflects Delex Pharma’s commitment to addressing critical healthcare needs in the Philippines, particularly in the fields of critical care, oncology, anesthesia, and medical devices.